{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:50:34Z","timestamp":1785876634363,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuroscience.2026.06.029","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:22:39Z","timestamp":1781994159000},"page":"378-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Moyamoya disease and angiogenesis: a quantitative analysis of key angiogenic markers"],"prefix":"10.1016","volume":"610","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4910-1796","authenticated-orcid":false,"given":"Tulika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9123-5713","authenticated-orcid":false,"given":"Ranjana","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-0615","authenticated-orcid":false,"given":"Munish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-4391","authenticated-orcid":false,"given":"Veena","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.029_b0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00018-022-04348-5","article-title":"Biological aspects in controlling angiogenesis: current progress","volume":"79","author":"Akbarian","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.029_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcp.1041470202","article-title":"Altered cellular responses to serum mitogens, including platelet\u2010derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease","volume":"147","author":"Aoyagi","year":"1991","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuroscience.2026.06.029_bib271","volume":"14","year":"2013"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.029_b0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cvr\/cvq105","article-title":"Vascular endothelial growth factors and vascular permeability","volume":"87","author":"Bates","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-4-S1-P4","article-title":"Increase of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems via allosteric receptor-receptor interaction","volume":"4","author":"Borroto-Escuela","year":"2015","journal-title":"Springerplus"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.029_b0025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","article-title":"Signaling and functions of angiopoietin-1 in vascular protection","volume":"98","author":"Brindle","year":"2006","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.029_b0030","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2009.1.FOCUS08310","article-title":"Moyamoya disease: a summary","volume":"26","author":"Burke","year":"2009","journal-title":"Neurosurg. Focus"},{"issue":"16","key":"10.1016\/j.neuroscience.2026.06.029_b0035","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.3390\/jcm10163628","article-title":"Clinical management of moyamoya patients","volume":"10","author":"Canavero","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.029_b0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3171\/2023.4.JNS23479","article-title":"Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization","volume":"139","author":"Chen","year":"2023","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0045","article-title":"TGF\u03b21 as a predictive biomarker for collateral formation within ischemic moyamoya disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0050","doi-asserted-by":"crossref","unstructured":"Chilikuri G, Job A, Vishwanathan A, Joshi V (2024) A systematic review of etiopathogenesis and treatment modalities for Moyamoya disease. medRxiv:2024.2008. 2010.24311757.","DOI":"10.1101\/2024.08.10.24311757"},{"key":"10.1016\/j.neuroscience.2026.06.029_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/0100-3984.2021.0010","article-title":"Moyamoya disease and syndrome: a review","volume":"55","author":"Demartini","year":"2022","journal-title":"Radiol. Bras."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.029_b0060","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cells10113242","article-title":"The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration","volume":"10","author":"Farooq","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.06.029_b0065","article-title":"Pathophysiology of vascular stenosis and remodeling in moyamoya disease","volume":"12","author":"Fox","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.029_b0075","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/acn3.52076","article-title":"Angiopoietin\u20102 associates with poor prognosis in Moyamoya angiopathy","volume":"11","author":"Gorla","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.029_b0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2394-8108.166377","article-title":"Review of past and present research on experimental models of moyamoya disease","volume":"1","author":"Hamauchi","year":"2015","journal-title":"Brain Circ."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.029_b0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.029_b0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","article-title":"Tumour vascularization: sprouting angiogenesis and beyond","volume":"26","author":"Hillen","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.029_b0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","article-title":"Role of transforming growth factor\u2014\u03b21 in the pathogenesis of moyamoya disease","volume":"89","author":"Hojo","year":"1998","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.029_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1096\/fj.05-5086com","article-title":"Calcium signaling stimulates translation of HIF\u2010\u03b1 during hypoxia","volume":"20","author":"Hui","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12860-017-0127-y","article-title":"Release of endothelial cell associated VEGFR2 during TGF-\u03b2 modulated angiogenesis in vitro","volume":"18","author":"Jarad","year":"2017","journal-title":"BMC Cell Biol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.029_b0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.06.029_b0120","article-title":"Glycosylation: a new signaling paradigm for the neurovascular diseases","author":"Kaur","year":"2023","journal-title":"Life Sc."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J. Stroke"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.029_b0130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.029_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/cells8050455","article-title":"Cross-talk between fibroblast growth factor receptors and other cell surface proteins","volume":"8","author":"Latko","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jvs.2013.02.240","article-title":"Hypoxia-inducible factor pathway and diseases of the vascular wall","volume":"58","author":"Lim","year":"2013","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0150","first-page":"699","article-title":"TGF-\u03b2 signaling: a complex role in tumorigenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0160","series-title":"Genetics and Pathophysiology of Moyamoya, a Rare Cerebrovascular","author":"Madou","year":"2021"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.029_b0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1582-4934.2008.00254.x","article-title":"Intra and extravascular transmembrane signalling of angiopoietin\u20101\u2010Tie2 receptor in health and disease","volume":"12","author":"Makinde","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.029_b0170","first-page":"182","article-title":"Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders","volume":"27","author":"Malek","year":"1997","journal-title":"Pediatr. Neurosurg."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.029_b0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1272\/jnms.JNMS.2024_91-215","article-title":"RNF213-related vasculopathy: various systemic vascular diseases involving RNF213 gene mutations","volume":"91","author":"Murai","year":"2024","journal-title":"J. Nippon Med. Sch."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.029_b0180","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.ajpath.2016.08.015","article-title":"Basic fibroblast growth factor induces angiogenic properties of fibrocytes to stimulate vascular formation during wound healing","volume":"186","author":"Nakamichi","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.029_b0185","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s11010-022-04452-x","article-title":"Studying molecular signaling in major angiogenic diseases","volume":"477","author":"Nathan","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.neuroscience.2026.06.029_b0190","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.3390\/ijms22137220","article-title":"Hypoxia and hypoxia-inducible factor signaling in muscular dystrophies: cause and consequences","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0195","unstructured":"Parisio, C., 2022 VEGF-A\/VEGFRs system in neuropathies: a crossroad between pain and neuroprotection."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0200","unstructured":"Pattarini, L., 2009. Post-translational modifications and molecular interactions regulating VEGFR2 activity."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.029_b0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","article-title":"Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease","volume":"40","author":"Rafat","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2026.06.029_b0210","first-page":"39","article-title":"Metalloproteinases and neurodegenerative diseases: pathophysiological and therapeutic perspectives","author":"Rosenberg","year":"2015","journal-title":"Metalloprotein. Med."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0215","article-title":"Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease: a review of the literature","volume":"3","author":"Ryan","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2017.12.002","article-title":"Important signals regulating coronary artery angiogenesis","volume":"117","author":"Shoeibi","year":"2018","journal-title":"Microvasc. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.029_b0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1227\/01.NEU.0000249275.87310.FF","article-title":"Expression of hypoxia-inducing factor-1\u03b1 and endoglin in intimal hyperplasia of the middle cerebral artery of patients with moyamoya disease","volume":"60","author":"Takagi","year":"2007","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.029_b0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","article-title":"Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease","volume":"24","author":"Takekawa","year":"2004","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.029_b0235","first-page":"58","article-title":"Stroke in Asia","volume":"14","author":"Tan","year":"2024","journal-title":"Cerebrovasc. Dis. Extra"},{"key":"10.1016\/j.neuroscience.2026.06.029_bib272","series-title":"Nina A Hilkens","author":"Unit","year":"2024"},{"key":"10.1016\/j.neuroscience.2026.06.029_b0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.wneu.2021.11.026","article-title":"Moyamoya vasculopathy: cause, clinical manifestations, neuroradiologic features, and surgical management","volume":"159","author":"Velo","year":"2022","journal-title":"World Neurosurg."},{"issue":"7058","key":"10.1016\/j.neuroscience.2026.06.029_b0245","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.029_b0250","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.01-0944rev","article-title":"Cellular adaptation to hypoxia: O2\u2010sensing protein hydroxylases, hypoxia\u2010inducible transcription factors, and O2\u2010regulated gene expression","volume":"16","author":"Wenger","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2026.06.029_b0255","doi-asserted-by":"crossref","unstructured":"Wietecha MS, Cerny WL, DiPietro LA (2012) Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis. New Perspect. Regen. 3-32.","DOI":"10.1007\/82_2012_287"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.029_b0260","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1161\/STROKEAHA.122.039961","article-title":"Differentiation of fibroblasts into myofibroblasts in the arachnoid membrane of moyamoya disease","volume":"53","author":"Yamamoto","year":"2022","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.029_b0265","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7150\/ijms.16489","article-title":"Clinical importance of the middle meningeal artery: a review of the literature","volume":"13","author":"Yu","year":"2016","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.029_b0270","first-page":"1977","article-title":"Epidemiology, diagnosis and treatment of moyamoya disease","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:23:11Z","timestamp":1785874991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226004185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S0306452226004185"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.029","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moyamoya disease and angiogenesis: a quantitative analysis of key angiogenic markers","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}